<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>242152</rcn>
  <id>101046182</id>
  <acronym>iMPact</acronym>
  <teaser>The current global COVID-19 pandemic has caused severe health and socio-economic challenges. Despite significant improvements in the treatment of critical COVID-19 patients and advances in vaccine development, there is still an urgent need for safe and effective...</teaser>
  <objective>The current global COVID-19 pandemic has caused severe health and socio-economic challenges. Despite significant improvements in the treatment of critical COVID-19 patients and advances in vaccine development, there is still an urgent need for safe and effective early-intervention treatments. To reduce disease burden, hospitalization time, and mortality, it is of critical importance to halt disease progression in early (mild-to-moderate) stages.  

Our new drug, MP1032, has a dual mode of action, targeting two important mechanisms (immune system overactivation and viral replication) in the early development of COVID-19. Its unique mechanism of self-regulation prevents immune-suppression, which is critical for early intervention. In combination with the oral availability, favourable safety profile, rapid and affordable production scale-up, and potential to work against viral variants, MP1032 is the ideal candidate for early treatment of COVID-19, which can also be used safely in high-risk patients. Therefore, the iMPact project aims to clinically validate MP1032 in a Phase II trial for its ability to stop COVID-19 disease progression. The outcome of the project shall serve as a basis for follow-up rapid Phase IIb/III development and market registration.  

Four international SMEs will work together in the iMPact project to achieve the objectives: 1) To demonstrate the efficacy of MP-1032 in hospitalized COVID-19 patients, 2) To demonstrate the effect of MP1032 on current SARS-CoV-2 variants, 3) To develop a GMP-compliant production scale-up process for MP1032, 4) To ensure that the clinical development plan is in line with regulatory requirements and 5) To collaborate with existing EU research networks. We have 29 clinical sites on board, and the required expertise for upscaling GMP manufacturing and regulatory preparation is available, ensuring that, by October 2022, MP1032 will be ready to progress to Phase IIb/III trials.</objective>
  <title>Novel, orally available immune modulator MP1032 with anti-SARS-CoV-2 and anti-cytokine activity</title>
  <totalCost>7988724.5</totalCost>
  <ecMaxContribution>7988724.25</ecMaxContribution>
  <startDate>2021-08-01</startDate>
  <endDate>2023-04-30</endDate>
  <ecSignatureDate>2021-11-16</ecSignatureDate>
  <duration>21</duration>
  <status>CLOSED</status>
  <keywords>RoS, anti-inflammatory, viral replication, self-regulatory, variant agnostic, early treatment, GMP production scale-up,PiP</keywords>
  <identifiers>
    <grantDoi>10.3030/101046182</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2025-02-07 18:25:43</sourceUpdateDate>
  <contentCreationDate>2022-09-26 10:28:24</contentCreationDate>
  <contentUpdateDate>2022-09-26 10:28:07</contentUpdateDate>
  <lastUpdateDate>2025-09-19 14:48:57</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <rcn>438375</rcn>
        <id>438375-drug-for-prevention-of-covid19-associated-illness-progression-from-early-to-severe-stages</id>
        <title>Novel oral drug for prevention of COVID-19 associated illness progression from early to severe stages</title>
        <contentUpdateDate>2023-02-20 20:44:01</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode>/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode>/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55322</rcn>
        <title>HORIZON-HLTH-2021-CORONA-01</title>
        <identifier>HORIZON-HLTH-2021-CORONA-01</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55322</rcn>
        <title>HORIZON-HLTH-2021-CORONA-01</title>
        <identifier>HORIZON-HLTH-2021-CORONA-01</identifier>
      </call>
      <organization netEcContribution="30945.39" totalCost="30945.39" source="corda" order="5" ecContribution="30945.39" terminated="false" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1978078</rcn>
        <id>888342103</id>
        <legalName>BLUST VOLKER</legalName>
        <shortName>PHOX Consulting e.U.</shortName>
        <address>
          <country>AT</country>
          <geolocation>47.2000338,13.199959</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedRegion">
              <name>Austria</name>
              <rcn>175540776</rcn>
              <nutsCode>AT</nutsCode>
              <euCode>AT</euCode>
              <isoCode>AT</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="146666" totalCost="146666.25" source="corda" order="2" ecContribution="146666" terminated="false" sme="false" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1978077</rcn>
        <id>890829280</id>
        <vatNumber>DE282485635</vatNumber>
        <legalName>IMMUNOLOGIK GMBH</legalName>
        <address>
          <street>AM BORSIGTURM 100</street>
          <city>Berlin</city>
          <postalCode>13507</postalCode>
          <country>DE</country>
          <geolocation>52.5835679,13.2814012</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Berlin</name>
              <rcn>221786112</rcn>
              <nutsCode>DE300</nutsCode>
              <parents>
                <region>
                  <name>Berlin</name>
                  <rcn>221786152</rcn>
                  <nutsCode>DE30</nutsCode>
                  <parents>
                    <region>
                      <name>Berlin</name>
                      <rcn>221788712</rcn>
                      <nutsCode>DE3</nutsCode>
                      <parents>
                        <region>
                          <name>Germany</name>
                          <rcn>221940264</rcn>
                          <nutsCode>DE</nutsCode>
                          <euCode>DE</euCode>
                          <isoCode>DE</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Germany</name>
              <rcn>221940264</rcn>
              <nutsCode>DE</nutsCode>
              <euCode>DE</euCode>
              <isoCode>DE</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="6683759.19" totalCost="7648407" source="corda" order="1" ecContribution="7648407" terminated="false" sme="false" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1978075</rcn>
        <id>890906880</id>
        <vatNumber>CHE109856841MWST</vatNumber>
        <legalName>METRIOPHARM AG</legalName>
        <address>
          <street>EUROPAALLEE 41</street>
          <city>ZURICH</city>
          <postalCode>8004</postalCode>
          <country>CH</country>
          <geolocation>47.368577,8.5370377</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Zürich</name>
              <rcn>1465385</rcn>
              <nutsCode>CH040</nutsCode>
              <parents>
                <region>
                  <name>Zürich</name>
                  <rcn>1464888</rcn>
                  <nutsCode>CH04</nutsCode>
                  <parents>
                    <region>
                      <name>Schweiz/Suisse/Svizzera</name>
                      <rcn>1464884</rcn>
                      <nutsCode>CH0</nutsCode>
                      <parents>
                        <region>
                          <name>Switzerland</name>
                          <rcn>205949480</rcn>
                          <nutsCode>CH</nutsCode>
                          <euCode>CH</euCode>
                          <isoCode>CH</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Switzerland</name>
              <rcn>205949480</rcn>
              <nutsCode>CH</nutsCode>
              <euCode>CH</euCode>
              <isoCode>CH</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="159062.5" totalCost="159062.5" source="corda" order="3" ecContribution="159062.5" terminated="false" sme="true" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1955448</rcn>
        <id>906667634</id>
        <vatNumber>NL858324210B01</vatNumber>
        <legalName>Catalyze B.V.</legalName>
        <address>
          <street>JOOP-GEESINKWEG 167</street>
          <city>Amsterdam-Duivendrecht</city>
          <postalCode>1114 AB</postalCode>
          <country>NL</country>
          <geolocation>52.3727598,4.8936041</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <rcn>1471664</rcn>
              <nutsCode>NL32B</nutsCode>
            </region>
            <region type="relatedRegion">
              <name>Netherlands</name>
              <rcn>391547432</rcn>
              <nutsCode>NL</nutsCode>
              <euCode>NL</euCode>
              <isoCode>NL</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="3643.36" totalCost="3643.36" source="corda" order="4" ecContribution="3643.36" terminated="true" sme="true" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>3146231</rcn>
        <id>917400296</id>
        <vatNumber>ATU68209235</vatNumber>
        <legalName>MC TOXICOLOGY CONSULTING GMBH</legalName>
        <address>
          <street>SIEBENSTERNGASSE 31/8</street>
          <city>Wien</city>
          <postalCode>1070</postalCode>
          <country>AT</country>
          <geolocation>48.2022475,16.3509751</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Wien</name>
              <rcn>175378624</rcn>
              <nutsCode>AT130</nutsCode>
              <parents>
                <region>
                  <name>Wien</name>
                  <rcn>175378664</rcn>
                  <nutsCode>AT13</nutsCode>
                  <parents>
                    <region>
                      <name>Ostösterreich</name>
                      <rcn>1465444</rcn>
                      <nutsCode>AT1</nutsCode>
                      <parents>
                        <region>
                          <name>Austria</name>
                          <rcn>175540776</rcn>
                          <nutsCode>AT</nutsCode>
                          <euCode>AT</euCode>
                          <isoCode>AT</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Austria</name>
              <rcn>175540776</rcn>
              <nutsCode>AT</nutsCode>
              <euCode>AT</euCode>
              <isoCode>AT</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="964647.81" totalCost="0" source="corda" order="1" ecContribution="0" terminated="false" sme="true" type="thirdParty">
        <availableLanguages>en</availableLanguages>
        <rcn>1978080</rcn>
        <id>889909817</id>
        <vatNumber>DE282232503</vatNumber>
        <legalName>METRIOPHARM DEUTSCHLAND GMBH</legalName>
        <address>
          <street>AM BORSIGTURM 100</street>
          <city>Berlin</city>
          <postalCode>13507</postalCode>
          <country>DE</country>
          <geolocation>52.5835679,13.2814012</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Berlin</name>
              <rcn>221786112</rcn>
              <nutsCode>DE300</nutsCode>
              <parents>
                <region>
                  <name>Berlin</name>
                  <rcn>221786152</rcn>
                  <nutsCode>DE30</nutsCode>
                  <parents>
                    <region>
                      <name>Berlin</name>
                      <rcn>221788712</rcn>
                      <nutsCode>DE3</nutsCode>
                      <parents>
                        <region>
                          <name>Germany</name>
                          <rcn>221940264</rcn>
                          <nutsCode>DE</nutsCode>
                          <euCode>DE</euCode>
                          <isoCode>DE</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Germany</name>
              <rcn>221940264</rcn>
              <nutsCode>DE</nutsCode>
              <euCode>DE</euCode>
              <isoCode>DE</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705741</rcn>
        <id>HORIZON.2.1</id>
        <code>HORIZON.2.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.2.1</pga>
        <title>Health</title>
        <parent>
          <programme>
            <rcn>705740</rcn>
            <code>HORIZON.2</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>705891</rcn>
        <id>HORIZON_HORIZON-HLTH-2021-CORONA-01-01</id>
        <code>HORIZON-HLTH-2021-CORONA-01-01</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>Vaccines &amp; therapeutic clinical trials to boost COVID-19 prevention and treatment</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453813</code>
              <title>Interventional clinical trials</title>
              <displayCode>/Interventional clinical trials</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43457239</code>
              <title>Severe acute respiratory syndrome</title>
              <displayCode>/Severe acute respiratory syndrome</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450302</code>
              <title>Clinical development, Phase I</title>
              <displayCode>/Clinical development, Phase I</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458724</code>
              <title>Viruses</title>
              <displayCode>/Viruses</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450305</code>
              <title>Clinical development, Phase II</title>
              <displayCode>/Clinical development, Phase II</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43452478</code>
              <title>Gender in clinical medicine</title>
              <displayCode>/Gender in clinical medicine</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43448916</code>
              <title>Activation immunotherapies</title>
              <displayCode>/Activation immunotherapies</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43456990</code>
              <title>SARS</title>
              <displayCode>/SARS</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458634</code>
              <title>Vaccines</title>
              <displayCode>/Vaccines</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450299</code>
              <title>Clinical data</title>
              <displayCode>/Clinical data</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43457833</code>
              <title>Statistics in clinical trials, Phase II</title>
              <displayCode>/Statistics in clinical trials, Phase II</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43451157</code>
              <title>Drug development, clinical phases</title>
              <displayCode>/Drug development, clinical phases</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43457830</code>
              <title>Statistics in clinical trials, Phase I</title>
              <displayCode>/Statistics in clinical trials, Phase I</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450338</code>
              <title>Clinical trials</title>
              <displayCode>/Clinical trials</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43455727</code>
              <title>Pharmaceutical development</title>
              <displayCode>/Pharmaceutical development</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedLegalBasis" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>705745</rcn>
        <id>HORIZON.2.1.4</id>
        <code>HORIZON.2.1.4</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.2.1.4</pga>
        <title>Infectious Diseases, including poverty-related and neglected diseases</title>
        <parent>
          <programme>
            <rcn>705741</rcn>
            <code>HORIZON.2.1</code>
            <parent>
              <programme>
                <rcn>705740</rcn>
                <code>HORIZON.2</code>
                <parent>
                  <programme>
                    <rcn>705725</rcn>
                    <code>HORIZON</code>
                  </programme>
                </parent>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>971756</rcn>
        <id>101046182_18_DELIVHORIZON</id>
        <title>Submission of scientific papers for publication</title>
        <description>Scientific papers on the findings submitted for publication in peerreviewed scientific and medical journals and respectively regulatory journals Preference will be given to submitting papers for publication in international openaccess scientific journals with as high impact as possible</description>
        <sourceUpdateDate>2023-08-28 00:52:12</sourceUpdateDate>
        <contentUpdateDate>2023-09-08 13:58:16</contentUpdateDate>
        <relations>
          <associations>
            <webLink source="corda" type="projectDeliverable" represents="project">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <id>75b06b26d5ad5f71e8d1c78ff1aa9c6d</id>
              <physUrl>https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e50077093d&amp;appId=PPGMS</physUrl>
              <defaultLanguage>en</defaultLanguage>
            </webLink>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/deliverable</code>
              <title>Project deliverable</title>
              <description>Result: Project deliverables</description>
              <displayCode>/Project deliverable</displayCode>
            </category>
            <category classification="deliverableType" type="isDeliveredAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/R</code>
              <title>Documents, reports</title>
              <displayCode>/Documents, reports</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1237365</rcn>
        <id>101046182_E1EC57FD71DE1E9B8DB084799399B21A_IPRHORIZON</id>
        <title>5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE FOR TREATMENT OF ACUTE LUNG INJURY</title>
        <details>
          <iprAwarded></iprAwarded>
          <iprNumber>21000028</iprNumber>
          <iprDate>2021-03-24</iprDate>
          <iprPrefix>20</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages>en</availableLanguages>
              <rcn>1978075</rcn>
              <id>890906880</id>
              <vatNumber>CHE109856841MWST</vatNumber>
              <legalName>METRIOPHARM AG</legalName>
              <address>
                <street>EUROPAALLEE 41</street>
                <city>ZURICH</city>
                <postalCode>8004</postalCode>
                <country>CH</country>
                <geolocation>47.368577,8.5370377</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <name>Zürich</name>
                    <rcn>1465385</rcn>
                    <nutsCode>CH040</nutsCode>
                    <parents>
                      <region>
                        <name>Zürich</name>
                        <rcn>1464888</rcn>
                        <nutsCode>CH04</nutsCode>
                        <parents>
                          <region>
                            <name>Schweiz/Suisse/Svizzera</name>
                            <rcn>1464884</rcn>
                            <nutsCode>CH0</nutsCode>
                            <parents>
                              <region>
                                <name>Switzerland</name>
                                <rcn>205949480</rcn>
                                <nutsCode>CH</nutsCode>
                                <euCode>CH</euCode>
                                <isoCode>CH</isoCode>
                              </region>
                            </parents>
                          </region>
                        </parents>
                      </region>
                    </parents>
                  </region>
                  <region type="relatedRegion">
                    <name>Switzerland</name>
                    <rcn>205949480</rcn>
                    <nutsCode>CH</nutsCode>
                    <euCode>CH</euCode>
                    <isoCode>CH</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode>/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PATENT</code>
              <title>Patent</title>
              <displayCode>/Patent</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1237357</rcn>
        <id>101046182_4AF429471ED81E21745CCF48A0109B51_IPRHORIZON</id>
        <title>LUMINOL FOR THE PROPHYLAXIS AND THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION</title>
        <details>
          <iprAwarded></iprAwarded>
          <iprNumber>21000150</iprNumber>
          <iprDate>2021-12-01</iprDate>
          <iprPrefix>20</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages>en</availableLanguages>
              <rcn>1978075</rcn>
              <id>890906880</id>
              <vatNumber>CHE109856841MWST</vatNumber>
              <legalName>METRIOPHARM AG</legalName>
              <address>
                <street>EUROPAALLEE 41</street>
                <city>ZURICH</city>
                <postalCode>8004</postalCode>
                <country>CH</country>
                <geolocation>47.368577,8.5370377</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <name>Zürich</name>
                    <rcn>1465385</rcn>
                    <nutsCode>CH040</nutsCode>
                    <parents>
                      <region>
                        <name>Zürich</name>
                        <rcn>1464888</rcn>
                        <nutsCode>CH04</nutsCode>
                        <parents>
                          <region>
                            <name>Schweiz/Suisse/Svizzera</name>
                            <rcn>1464884</rcn>
                            <nutsCode>CH0</nutsCode>
                            <parents>
                              <region>
                                <name>Switzerland</name>
                                <rcn>205949480</rcn>
                                <nutsCode>CH</nutsCode>
                                <euCode>CH</euCode>
                                <isoCode>CH</isoCode>
                              </region>
                            </parents>
                          </region>
                        </parents>
                      </region>
                    </parents>
                  </region>
                  <region type="relatedRegion">
                    <name>Switzerland</name>
                    <rcn>205949480</rcn>
                    <nutsCode>CH</nutsCode>
                    <euCode>CH</euCode>
                    <isoCode>CH</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode>/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PATENT</code>
              <title>Patent</title>
              <displayCode>/Patent</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>911809</rcn>
        <id>101046182_PSHORIZON</id>
        <title>Periodic Reporting for period 2 - iMPact (Novel, orally available immune modulator MP1032 with anti-SARS-CoV-2 and anti-cytokine activity)</title>
        <description>periodic</description>
        <teaser>The global pandemic caused by SARS-CoV-2 has resulted in significant health and socio-economic challenges worldwide. Early intervention in COVID-19 is crucial to prevent severe disease and mortality.To reduce the disease burden and alleviate strain on healthcare systems, it is...</teaser>
        <sourceUpdateDate>2023-10-14 15:46:58</sourceUpdateDate>
        <contentUpdateDate>2023-02-07 15:03:47</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode>/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>872127</rcn>
        <id>101046182_14_DELIVHORIZON</id>
        <title>Project website</title>
        <description>Launch of project website that provides project information background objectives approach results and news for selected stakeholders in clearly signposted sections for different users researchers collaborators clinicians patients etc</description>
        <sourceUpdateDate>2022-06-15 10:01:26</sourceUpdateDate>
        <contentUpdateDate>2022-09-26 10:49:23</contentUpdateDate>
        <relations>
          <associations>
            <webLink source="corda" type="projectDeliverable" represents="project">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <id>913aae7f876b7f06d7c67629f0903111</id>
              <physUrl>https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5e79030c6&amp;appId=PPGMS</physUrl>
              <defaultLanguage>en</defaultLanguage>
            </webLink>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/deliverable</code>
              <title>Project deliverable</title>
              <description>Result: Project deliverables</description>
              <displayCode>/Project deliverable</displayCode>
            </category>
            <category classification="deliverableType" type="isDeliveredAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/DEC</code>
              <title>Websites, patent fillings, videos etc.</title>
              <displayCode>/Websites, patent fillings, videos etc.</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1237366</rcn>
        <id>101046182_049ECF37C67D9604294F4F1B4A28FDF9_IPRHORIZON</id>
        <title>COMPOUND FOR THE TREATMENT OF CORONAVIRAL INFECTIONS</title>
        <details>
          <iprAwarded></iprAwarded>
          <iprNumber>21000071</iprNumber>
          <iprDate>2021-06-09</iprDate>
          <iprPrefix>20</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages>en</availableLanguages>
              <rcn>1978075</rcn>
              <id>890906880</id>
              <vatNumber>CHE109856841MWST</vatNumber>
              <legalName>METRIOPHARM AG</legalName>
              <address>
                <street>EUROPAALLEE 41</street>
                <city>ZURICH</city>
                <postalCode>8004</postalCode>
                <country>CH</country>
                <geolocation>47.368577,8.5370377</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <name>Zürich</name>
                    <rcn>1465385</rcn>
                    <nutsCode>CH040</nutsCode>
                    <parents>
                      <region>
                        <name>Zürich</name>
                        <rcn>1464888</rcn>
                        <nutsCode>CH04</nutsCode>
                        <parents>
                          <region>
                            <name>Schweiz/Suisse/Svizzera</name>
                            <rcn>1464884</rcn>
                            <nutsCode>CH0</nutsCode>
                            <parents>
                              <region>
                                <name>Switzerland</name>
                                <rcn>205949480</rcn>
                                <nutsCode>CH</nutsCode>
                                <euCode>CH</euCode>
                                <isoCode>CH</isoCode>
                              </region>
                            </parents>
                          </region>
                        </parents>
                      </region>
                    </parents>
                  </region>
                  <region type="relatedRegion">
                    <name>Switzerland</name>
                    <rcn>205949480</rcn>
                    <nutsCode>CH</nutsCode>
                    <euCode>CH</euCode>
                    <isoCode>CH</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode>/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PATENT</code>
              <title>Patent</title>
              <displayCode>/Patent</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/29/101/553/1353</code>
        <title>mortality</title>
        <displayCode>/social sciences/sociology/demography/mortality</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/33/137/133/9678651</code>
        <title>pandemics</title>
        <displayCode>/medical and health sciences/health sciences/public health/epidemiology/pandemics</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/33/121/44109686/8132740</code>
        <title>coronaviruses</title>
        <displayCode>/medical and health sciences/health sciences/infectious diseases/RNA viruses/coronaviruses</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/159/653/1439</code>
        <title>vaccines</title>
        <displayCode>/medical and health sciences/basic medicine/pharmacology and pharmacy/pharmaceutical drugs/vaccines</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-RIA</code>
        <title>HORIZON  Research and Innovation Actions</title>
        <description>HORIZON  Research and Innovation Actions</description>
        <displayCode>/HORIZON  Research and Innovation Actions</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>